Surgalign Holdings Inc
NASDAQ:SRGA
Surgalign Holdings Inc
Research & Development
Surgalign Holdings Inc
Research & Development Peer Comparison
Competitive Research & Development Analysis
Latest Figures & CAGR of Competitors
Company | Research & Development | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Surgalign Holdings Inc
NASDAQ:SRGA
|
Research & Development
-$14.2m
|
CAGR 3-Years
5%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
-1%
|
|
Cooper Companies Inc
NYSE:COO
|
Research & Development
-$145.3m
|
CAGR 3-Years
-16%
|
CAGR 5-Years
-11%
|
CAGR 10-Years
-9%
|
|
DENTSPLY SIRONA Inc
NASDAQ:XRAY
|
Research & Development
-$180m
|
CAGR 3-Years
-3%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Align Technology Inc
NASDAQ:ALGN
|
Research & Development
-$351.2m
|
CAGR 3-Years
-23%
|
CAGR 5-Years
-21%
|
CAGR 10-Years
-22%
|
|
Lantheus Holdings Inc
NASDAQ:LNTH
|
Research & Development
-$95.2m
|
CAGR 3-Years
-35%
|
CAGR 5-Years
-40%
|
CAGR 10-Years
-16%
|
See Also
What is Surgalign Holdings Inc's Research & Development?
Research & Development
-14.2m
USD
Based on the financial report for Mar 31, 2023, Surgalign Holdings Inc's Research & Development amounts to -14.2m USD.
What is Surgalign Holdings Inc's Research & Development growth rate?
Research & Development CAGR 10Y
-1%
Over the last year, the Research & Development growth was 8%. The average annual Research & Development growth rates for Surgalign Holdings Inc have been 5% over the past three years , -2% over the past five years , and -1% over the past ten years .